ESMO BC-2025

ESMO BC-2025
May 14-16, 2025
Munich, Germany

European Society of Medical Oncology Breast Cancer Congress 2025 .

Explore more information for Gilead Oncology therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (2)

    Pooled safety analysis of sacituzumab govitecan (SG) in metastatic breast cancer (mBC), including data from patients (pts) treated in NA/EU and Asia

    • Author(s): Rugo, HS
    • trodelvy
    • Oncology
    • Poster

    Sacituzumab govitecan in patients previously treated unresectable locally advanced or metastatic triple-negative breast cancer within routine clinical practice in Spain (TROPSPAIN): Interim analysis of a retrospective, observational, multicentre study

    • Author(s): Munoz, M
    • trodelvy
    • Oncology
    • Poster